Aerobic Exercise in Patients With CKD
Effects of a Program of Aerobic Exercise on the Profile of Intestinal Microbiota and Cardiovascular Markers in Patients With Chronic Kidney Disease
1 other identifier
interventional
32
1 country
1
Brief Summary
Patients with chronic kidney disease (CKD), especially those who are on dialysis, have a high prevalence of cardiovascular mortality and among the risk factors; inflammation and oxidative stress stand out. Furthermore, recently this scenario, beyond those alterations found in these patients, it has been suggested that the imbalance gut microbiota might be a new factor of cardiovascular risk. Some treatment strategies have been studied in order to modulate the gut microbiota and inflammation, such as the implementation of exercise programs. However, the effects of exercise on the modulation of the gut microflora and inflammation have not been evaluated in these patients. The aim of this project is to investigate possible changes in gut microbiota, levels of uremic toxins and inflammatory and cardiovascular markers in CKD patients on hemodialysis, after application of a training program with aerobic exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 25, 2019
CompletedFirst Posted
Study publicly available on registry
May 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedJanuary 5, 2022
January 1, 2022
4.9 years
April 25, 2019
January 4, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Inflammatory biomarkers
Get blood samples to evaluate changes in the expression of transcription factors (nuclear factor erythroid 2-related factor 2 and Nuclear Factor-kB) that modulate inflammation.
12 weeks
Uremic toxins
Evaluation of P-Cresyl Sulfate, Indoxyl Sulfate (IS), Indole 3-Acetic Acid, Trimethyl N-oxide (TMAO) and lipopolysaccharides (LPSs).
12 weeks
Study Arms (2)
Exercise group
ACTIVE COMPARATORIntradialytic aerobic exercise, 3 times a week, for 12 weeks.
Non-exercise group
NO INTERVENTIONWithout intradialytic aerobic exercise for 12 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Sedentary men and women between the ages of 18 and 60;
- patients with hemodialysis only with vascular access arteriovenous fistula who have been in dialysis for more than 6 months
- patients with hemoglobin levels greater than 10 mg / dL.
You may not qualify if:
- Patients taking catabolizing drugs, vitamin supplements, antioxidants, probiotics, prebiotics, symbiotics and antibiotics;
- patients with autoimmune, infectious, cancer, AIDS,
- patients with clinically unstable diseases (AMI less than 1 year, unstable angina, atrial fibrillation, significant cardiac arrhythmia and acute disease in the last month)
- patients with frequent hypotension during dialysis
- patients with chronic obstructive pulmonary disease and glycemic lability;
- incapacitated to perform exercise (amputation without prosthesis);
- musculoskeletal pain at rest or with minimal physical activity,
- inability to sit or walk without assistance,
- dyspnoea at rest or at slight exertion (NYHA III and IV).
- impediment to completing the proposed exercise protocol (travel, imminent renal transplantation).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Denise Mafra
Rio de Janeiro, Rio de Janeiro, 22260-050, Brazil
Related Publications (2)
Brito JS, Borges NA, Reis DCMV, Silva GSD, Fonseca LDS, Ribeiro MMF, Chermut TR, Moura MC, Oliveira LC, Paiva BR, Cardozo LF, Capistrano ESM, Mafra D. Effects of intradialytic bicycle ergometer exercise on transcription factors NF-kB and Nrf2 in patients with chronic kidney disease: A randomized crossover clinical trial. J Bodyw Mov Ther. 2024 Oct;40:1492-1501. doi: 10.1016/j.jbmt.2024.08.003. Epub 2024 Aug 8.
PMID: 39593477DERIVEDBrito JS, Reis D, Silva G, Fonseca L, Ribeiro M, Chermut T, Oliveira L, Borges NA, Ribeiro-Alves M, Mafra D. Bicycle ergometer exercise during hemodialysis and its impact on quality of life, aerobic fitness and dialysis adequacy: A pilot study. Complement Ther Clin Pract. 2022 Nov;49:101669. doi: 10.1016/j.ctcp.2022.101669. Epub 2022 Sep 17.
PMID: 36152526DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Denise Mafra, PhD
Federal university fluminense
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2019
First Posted
May 5, 2020
Study Start
January 1, 2017
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
January 5, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share